1199556-86-9

Basic information

• Product Name: 2-(2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione
• Synonyms: 2-(2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione
• CAS NO: 1199556-86-9
• Molecular Formula: C₂₀H₁₆BrNO₄
• Molecular Weight: 414.24934
• EINECS: -0
• Mol File: 1199556-86-9.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 529.1±50.0 °C(Predicted)
• Appearance: /
• Density: 1.65±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: -2.37±0.20(Predicted)
• CAS DataBase Reference: 2-(2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione(1199556-86-9)
• EPA Substance Registry System: 2-(2-(4-broMophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione(1199556-86-9)

Safety Data

• Hazardous Substances Data: 1199556-86-9(Hazardous Substances Data)

Usage

General Description

2-(2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-yl)isoindoline-1,3-dione is a chemical compound with a complex structure containing a spirocyclic ring system and an isoindoline-1,3-dione moiety. The presence of a bromine atom attached to a phenyl ring indicates that this compound is a derivative of phenyl. The spirocyclic ring system and the isoindoline-1,3-dione group are likely to be involved in the compound's biological activity or pharmacological properties. The molecule's structure suggests that it may possess interesting chemical and biological properties, making it a potential candidate for further exploration in drug discovery and development. However, further research and studies are needed to fully understand the potential uses and effects of this chemical compound.

Upstream product

• 1199557-05-5 tert-butyl [2-(4-bromophenyl)-5,8-dioxaspiro[3.4]oct-2-yl]carbamate 
• 22509-74-6 N-ethoxycarbonylphthalimide 
• 1199556-85-8 2-(4-bromophenyl)-5,8-dioxaspiro[3.4]octan-2-amine 

Downstream Products

• 1199556-88-1 2-[trans-1-(4-bromophenyl)-3-hydroxy-3-methylcyclobutyl]-1H-isoindole-1,3(2H)-dione 
• 1199556-89-2 2-[cis-1-(4-bromophenyl)-3-hydroxy-3-methylcyclobutyl]-1H-isoindole-1,3(2H)-dione 
• 1199556-90-5 2-{trans-3-hydroxy-3-methyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]cyclobutyl}-1H-isoindole-1,3(2H)-dione 
• 1199556-40-5 trans-3-amino-3-{4-[1-(difluoromethyl)-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl]phenyl}-1-methylcyclobutanol 
• 1199557-03-3 2-(trans-1-{4-[1-(difluoromethyl)-8-phenyl-[1,2,4]triazolo[4,3-a]-1,5-naphthyridin-7-yl]phenyl}-3-hydroxy-3-methylcyclobutyl)-1H-isoindole-1,3(2H)-dione 

Relevant articles and documents

INHIBITORS OF AKT ACTIVITY

The instant invention provides for compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting Akt activity by administering the compound to a patient in need of treatment of cancer.

INHIBITORS OF AKT ACTIVITY

The instant invention provides for substituted [1,2,4]triazolo[4,3-a]-1,5-naphthyridine compounds that inhibit Akt activity. In particular, the compounds disclosed selectively inhibit one or two of the Akt isoforms, preferably Akt1. The invention also pro